$90-million live attenuated vaccine contract has been proposed by Obama administration. The virus in a live attenuated vaccine works in vaccinated people without causing illness. It would be given in lower doses than a killed virus or an antigen subunit vaccine. Therefore it can increase existing vaccine supplies 30- to 100-fold. As part of the almost $1-billion contract, the US government has awarded Sanofi Pasteur $191 million, Novartis $150 million, CSL Biotherapies $180 million and GlaxoSmithKline (GSK) $38 million to supply H1N1 vaccine antigen.All this money flying around and no secretary of HHS yet ? Reminds me of the days of SARS, bird flu, and the Bush era when it was crucial to award these contracts. I guess all you need to award contracts is a new disease for a new administration. Just blame civits, chickens, and pigs... what's next capibaras ? pharma fat cats ? phat capibaras ?
No comments:
Post a Comment